Skip to main content

Proceeding contribution from Lord Walton of Detchant (Crossbench) in the House of Lords on Monday, 26 March 2012. It occurred during Debate on select committee report on Liaison Committee: Third Report.


Liaison Committee: Third Report

My Lords, I shall speak briefly. I have read the report of the Liaison Committee with great care. I think that it was carefully argued. I fully appreciate why, in times of financial constraint, it made the proposals that it did. However, we as a country depend on increasing our income and overcoming our deficit. There can be no question, in my opinion, that the development of science, education and technology will play a vital role in helping us to recover from the deficit state in which we find ourselves. Unfortunately, we are slow to take account of, develop and extend the results of scientific discovery—a problem that we have faced over many years. We live now in an era of evidence-based and translational medicine—meaning the ability to convert the results of basic science into developments in patient care and new methods of treatment of disease. It is crucial that the results of research in basic science, engineering and technology should do the same. Happily, the Government have put more money into scientific research. The Technology Strategy Board is making a major impact, and so, too, are a huge number of other important developments—but they need development and they need support. I have been in the House for 23 years. For 15 of those years, I served as a member of your Lordships' Committee on Science and Technology. I chaired an inquiry some years ago into research in the National Health Service. That was a privilege. The report of that sub-committee inquiry led to the Culyer report and then the Cooksey report, and ultimately to the introduction of the NHS research programme—and now the highly effective National Institute for Health Research. I worked on a small inquiry of the sub-committee which, curiously, in a limited field, dealt with the medicinal uses of cannabis and led eventually to the development of a standardised product of cannabis leaf that is now being sold across the world—used for absorption through the mucus membrane of the mouth—and that brings in money from across the world because of its effect in the treatment of multiple sclerosis. I could quote a lot of other inquiries that have been crucial: not least, for instance, the committee I chaired into complementary and alternative medicine, to try to bring a rational basis to the study of this particular area, in which a large amount of money is spent by very many people in this country. That report was taken on board by the National Institutes of Health in the United States as the basis for a programme of research on which it embarked, and into which it put money, to try to get an evidence base for that field of complementary medicine. I could quote many other examples—and many other examples have been quoted today. The reason I support the amendment tabled by my noble friend Lord Krebs is that the reports of the Science and Technology Committee in this House have not only had a major influence on government policy across the entire scientific field but have won the respect of Britain's scientific community. Above all, they have won the respect of the international scientific community. As the noble Lord, Lord Jenkin, said, the report on science and society was widely commended in the United States media. I could quote a huge number of other reports from the committee that have had a similar effect. It is absolutely crucial that the committee should continue to function in its present capacity. My noble friend Lord Krebs said, in his carefully argued and detailed letter in annexe 3 to the third report from the Liaison Committee, proposed, "““wider involvement of members in the committee activity of the House whilst preserving the advantages of a sessional committee””." He proposed a number of methods for co-opting members to each of the sub-committees and made it clear that he could continue with the two sub-committees of the science committee with co-opted members, increasing the involvement of other Members of the House. It would be a sad day if that committee, which has fulfilled such a vital role in Britain's science community, and which has received such outstanding credit from across the world, were to lose one of its sub-committees at a time when Britain needs much more development in science, engineering and technology. For that reason, I strongly support my noble friend Lord Krebs.


Secondary information

Type
Proceeding contribution
Reference
736 c1176-7 
Session
2010-12
Chamber / Committee
House of Lords chamber
Subjects
House of Lords Exports Legislation Membership Parliamentary scrutiny Public service Peers Small businesses Select committees European Union Committee Economic Affairs Committee Science and Technology Committee (HL) Select Committee on Communications
Legislation
Adoption and Children Act 2002
Children and Adoption Act 2006
Link
View this Proceeding contribution on www.publications.parliament.uk